Targets for active immunotherapy against pediatric solid tumors J. F. M. JacobsP. G. CoulieP. M. Hoogerbrugge Review Open access 14 November 2008 Pages: 831 - 841
Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteins Michael G. DoddsKlaus Stensgaard FrederiksenSteven D. Hughes Original Article 17 October 2008 Pages: 843 - 854
Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells Sonja VerheydenSoldano FerroneChristian Demanet Original Article 08 October 2008 Pages: 855 - 865
Apoptosis of CD4+CD25high T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2 Kerrington R. MolhoekChantel C. McSkimmingCraig L. Slingluff Jr Original Article 08 October 2008 Pages: 867 - 876
The immunosuppressive tumor microenvironment in hepatocellular carcinoma Yan-Li PangHua-Gang ZhangWei-Feng Chen Original Article 22 October 2008 Pages: 877 - 886
Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study Florian SchuetzKatrin EhlertPhilipp Beckhove Original Article 08 November 2008 Pages: 887 - 900
Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo Cornelia WurzenbergerViktor H. KoelzerCarole Bourquin Original Article 25 October 2008 Pages: 901 - 913
Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells Panagiotis KaragiannisJosef SingerSophia N. Karagiannis Original Article 22 October 2008 Pages: 915 - 930
Focal adhesion kinase as an immunotherapeutic target Hiroya KobayashiMakoto AzumiEsteban Celis Original Article 22 October 2008 Pages: 931 - 940
Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells Johanna K. MoralesMaciej KmieciakMasoud H. Manjili Original Article 01 November 2008 Pages: 941 - 953
Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients Mary T. LitzingerKenneth A. FoonClaudia Palena Original Article 14 November 2008 Pages: 955 - 965
HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody Wei WangYasuhiko NishiokaSaburo Sone Original Article 01 November 2008 Pages: 967 - 976
Lentiviral vectors encoding human MUC1-specific, MHC-unrestricted single-chain TCR and a fusion suicide gene: potential for universal and safe cancer immunotherapy Xiaochuan ChenWentao GaoOlivera J. Finn Original Article 21 November 2008 Pages: 977 - 987
Low representation of Fc receptor-like 1–5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia Tohid KazemiHossein Asgarian-OmranFazel Shokri Short Communication 19 September 2008 Pages: 989 - 996